Trigeminal Neuralgia (Tic Douloureux) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Trigeminal Neuralgia (Tic Douloureux) Clinical Trials Overview
The Trigeminal Neuralgia (Tic Douloureux) clinical trial report consists of 129 trials. The report provides an overview of the Trigeminal Neuralgia (Tic Douloureux) clinical trials scenario. The report provides top-line data relating to the clinical trials on Trigeminal Neuralgia (Tic Douloureux). It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report includes the names of prominent sponsors involved with conducting the Trigeminal Neuralgia (Tic Douloureux) clinical trials as well.
Key Regions | · Asia-Pacific
· Europe · North America · Middle East and Africa · South and Central America |
Key Countries | · China
· The US · India · Iran · The UK · Germany |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Biogen Inc
· Shanghai Fudan Forward S&T Co Ltd · AbbVie Inc · Jiangsu Pengyao Pharmaceuticals Inc · Merz Pharma GmbH & Co KgaA · Pfizer Inc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Trigeminal Neuralgia (Tic Douloureux) Clinical Trials Segmentation by Regions and Countries
Asia-Pacific led the Trigeminal Neuralgia (Tic Douloureux) clinical trials landscape with more than 43% of the clinical trials conducted there as of October 2023.
The key regions considered for Trigeminal Neuralgia (Tic Douloureux) clinical trials analysis are Asia-Pacific, Europe, North America, Middle East and Africa, and South and Central America.
In a country-wise analysis, as of October 2023, China accounted for the highest number of Trigeminal Neuralgia (Tic Douloureux) clinical trials, followed by the US.
G7 countries: Among the G7 (United States, United Kingdom, Germany, Canada, Japan, France, and Italy) countries, the UK has the highest proportion of Trigeminal Neuralgia (Tic Douloureux) to Central Nervous System clinical trials as of October 2023.
E7 countries: Among the E7 (China, India, Russia, Turkey, Brazil, Mexico, and Indonesia) countries, Mexico has the highest proportion of Trigeminal Neuralgia (Tic Douloureux) to Central Nervous System clinical trials as of October 2023.
Trigeminal Neuralgia (Tic Douloureux) Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Trigeminal Neuralgia (Tic Douloureux) Clinical Trials
Trigeminal Neuralgia (Tic Douloureux) Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Trigeminal Neuralgia (Tic Douloureux) clinical trials are company, institution, and the government. As of October 2023, the institution sponsor type dominated the Trigeminal Neuralgia (Tic Douloureux) clinical trials share, followed by company.
Trigeminal Neuralgia (Tic Douloureux) Clinical Trials Analysis by Sponsor Types, 2023 (%)
Buy Full Report for More Sponsor Type Insights into Trigeminal Neuralgia (Tic Douloureux) Clinical Trials
Trigeminal Neuralgia (Tic Douloureux) Clinical Trials - Competitive Landscape
In 2023, Biogen Inc has conducted the highest number of Trigeminal Neuralgia (Tic Douloureux) clinical trials.
Some of the leading sponsors for Trigeminal Neuralgia (Tic Douloureux) clinical trials are:
- Biogen Inc
- Shanghai Fudan Forward S&T Co Ltd
- AbbVie Inc
- Jiangsu Pengyao Pharmaceuticals Inc
- Merz Pharma GmbH & Co KgaA
- Pfizer Inc
Trigeminal Neuralgia (Tic Douloureux) Clinical Trials Analysis by Sponsors, 2023 (%)
Buy Full Report to Know More about the Leading Players of Trigeminal Neuralgia (Tic Douloureux) Clinical Trials
Segments Covered in the Report
Trigeminal Neuralgia (Tic Douloureux) Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- South and Central America
Trigeminal Neuralgia (Tic Douloureux) Clinical Trials Country Outlook (2023)
- China
- The US
- India
- Iran
- The UK
- Germany
Trigeminal Neuralgia (Tic Douloureux) Clinical Trials Sponsor Type Outlook (2023)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Shanghai Fudan Forward S&T Co Ltd
AbbVie Inc
Jiangsu Pengyao Pharmaceuticals Inc
Merz Pharma GmbH & Co KgaA
Pfizer Inc
Praxis Precision Medicines Inc
Viatris Inc
Zhejiang Jiuzhou Pharmaceutical Co Ltd
Acasti Pharma Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Trigeminal Neuralgia (Tic Douloureux) clinical trials?
Asia-Pacific accounted for the highest number of Trigeminal Neuralgia (Tic Douloureux) clinical trials as of October 2023.
-
Which country conducted the highest number of Trigeminal Neuralgia (Tic Douloureux) clinical trials?
China conducted the highest number of Trigeminal Neuralgia (Tic Douloureux) clinical trials as of October 2023.
-
Which sponsor type was the most prominent in the Trigeminal Neuralgia (Tic Douloureux) clinical trials?
Institution was the most prominent sponsor type for Trigeminal Neuralgia (Tic Douloureux) clinical trials.
-
Who are the leading sponsors of Trigeminal Neuralgia (Tic Douloureux) clinical trials?
Some of the leading sponsors of Trigeminal Neuralgia (Tic Douloureux) clinical trials are Biogen Inc, Shanghai Fudan Forward S&T Co Ltd, AbbVie Inc, Jiangsu Pengyao Pharmaceuticals Inc, Merz Pharma GmbH & Co KgaA, and Pfizer Inc, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.